Challenging conventional wisdom on a common cause of melanoma

Publicly released:
Australia; International; NSW; QLD
LIGHTFIELD STUDIOS/ Adobe Stock.
LIGHTFIELD STUDIOS/ Adobe Stock.

University of Queensland researchers have found a genetic mutation that causes melanoma to lie dormant in healthy skin, a finding that could improve screening of areas more prone to the disease.

Media release

From: The University of Queensland

University of Queensland researchers have found a genetic mutation that causes melanoma can lie dormant in healthy skin, a finding that could improve screening of areas more prone to the disease.

The mutation in the BRAF gene – commonly identified in melanoma tumours – was thought to only exist in moles and melanomas.

UQ Frazer Institute PhD candidate Katie Lee said it was assumed this particular mutation would almost always cause a mole or melanoma to form.

“We have found many examples of the BRAF mutation in normal skin, including skin next to a mole and a melanoma, as well as in sun-exposed and sun-protected skin,” Ms Lee said.

“Our research challenges conventional wisdom that BRAF is not generally found in normal skin and that it nearly always causes a melanoma or a mole to form.’’

Ms Lee said about 50 per cent of melanomas and up to 100 per cent of moles commonly had a mutation in the BRAF gene melanocytes – a type of skin cell responsible for pigment production.

The Dermatology Research Centre team examined the mutation in 97 skin samples from a high-risk Australian cohort that appeared normal to both the naked eye and under a microscope.

Most were taken from the participants’ backs and shoulders.

UQ Frazer InstituteAssociate Professor Mitchell Stark said the mutant cells appeared to be dormant, but would likely form a tumour under certain circumstances.

“However, just because you have this mutation, doesn’t mean you’ll develop skin cancer,” Dr Stark said.

“Other external factors are needed for the cells to become malignant.”

Dr Stark said the findings could improve patient screening and melanoma prevention by helping researchers map areas of skin with the mutation and categorising individuals by risk level.

“We noticed our study participants often had all their melanomas and other suspicious lesions removed from the same region of the back,’’ he said.

“If we can use our findings to show certain areas have more mutations, then we could focus treatment on those spots rather than the whole body.’’

Early detection and surgical removal of the disease offer the best chance of a cure.

The research was a collaboration with Associate Professor Robert L. Judson-Torres of the Huntsman Cancer Institute at The University of Utah.

The research is published in British Journal of Dermatology.

Journal/
conference:
British Journal of Dermatology
Research:Paper
Organisation/s: The University of Queensland, Garvan Institute of Medical Research
Funder: This work was supported by NIH/NCI R01CA229896 (to R.L.J.) and Cancer Center Support Grant P30CA042014, by the US Department of Defense (W81XWH2220005 to A.L.W.) and by the Cancer Research Collaboration supporting Legacy to Life (to A.L.W.). ZKT was supported by an Advance Queensland Early Career Research Fellowship. MSS also held a University of Queensland (UQ) Amplify Fellowship. This work was also generously supported by the Merchant Charitable Foundation, as well as Fellowships (APP110649 and APP2033440 (MSS), APP1043187 (RAS), APP1137127 HPS), a Scholarship (APP2013961 37 (KJL), Project Grants (APP1062935, APP1083612), and Centre for Research Excellence grants (APP1099021) from the National Health and Medical Research Council (NHMRC). The researchers acknowledge the direct financial support for the research reported in this publication provided by seed grants from the HCI Melanoma Research Center.
Media Contact/s
Contact details are only visible to registered journalists.